About Human C-C Chemokine Receptor Type 5 (CCR5) Stable Cell Line

C-C Chemokine Receptor Type 5 (CCR5), also known as CD195, is a Class A G protein-coupled receptor (GPCR) that belongs to the CC chemokine receptor family. CCR5 is primarily expressed on T lymphocytes, macrophages, dendritic cells, monocytes, and other immune cells, where it mediates cellular migration and immune responses. The receptor is activated by several endogenous chemokines, including CCL3 (MIP-1α), CCL4 (MIP-1β), and CCL5 (RANTES). Upon ligand binding, CCR5 primarily couples to Gi proteins, leading to inhibition of adenylate cyclase activity, intracellular calcium mobilization, activation of MAPK signaling pathways, and chemotactic migration of immune cells.

CCR5 plays a critical role in immune surveillance, inflammation, leukocyte trafficking, and host defense. Beyond its physiological functions, CCR5 is best known as a major co-receptor for HIV-1 entry into host cells. HIV utilizes CCR5 in conjunction with CD4 to infect T cells and macrophages, making CCR5 one of the most clinically important targets in infectious disease research. Genetic deletion of CCR5 (CCR5-Δ32 mutation) confers resistance to many HIV strains, further highlighting its therapeutic significance. In addition, CCR5 has been implicated in cancer progression, inflammatory diseases, autoimmune disorders, graft-versus-host disease, and tissue fibrosis.

eEnzyme's Human CCR5 Stable Cell Line provides a reliable and reproducible cellular platform for investigating CCR5-mediated signaling pathways and evaluating receptor-targeted therapeutics. The cell line enables quantitative assessment of chemokines, agonists, antagonists, neutralizing antibodies, and small-molecule inhibitors through calcium mobilization assays, reporter gene assays, chemotaxis studies, and other GPCR functional screening platforms. Researchers can utilize this stable cell line for receptor characterization, compound profiling, potency determination, lead optimization, and high-throughput screening applications supporting immunology, virology, oncology, and inflammation research.

Applications of the CCR5 Stable Cell Line

• CCR5 receptor pharmacology studies
• Chemokine signaling investigations
• HIV entry and antiviral drug discovery research
• Agonist and antagonist screening
• Antibody characterization and therapeutic development
• Immunology and inflammation studies
• Calcium mobilization and GPCR functional assays
• High-throughput screening applications

Biological Significance of CCR5

CCR5 is a key regulator of immune cell migration and inflammatory responses. Activation of CCR5 directs leukocyte trafficking to sites of infection, tissue injury, and inflammation through chemokine-mediated signaling pathways. The receptor is critically involved in both innate and adaptive immune responses and contributes to host defense against pathogens. CCR5 is also a major HIV-1 co-receptor, and blockade of CCR5 has become a validated therapeutic strategy for HIV treatment. Beyond infectious disease, aberrant CCR5 signaling has been linked to tumor metastasis, chronic inflammation, autoimmune disorders, fibrosis, and cardiovascular disease. Because of its broad biological importance and established clinical relevance, CCR5 remains one of the most intensively studied chemokine receptors in immunology, virology, oncology, and drug discovery. The CCR5 Stable Cell Line provides a valuable tool for studying receptor biology and advancing the development of next-generation CCR5-targeted therapeutics.